INDO US BIO-TECH | VENKYS | INDO US BIO-TECH/ VENKYS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 35.9 | 117.8% | View Chart |
P/BV | x | 8.6 | 2.0 | 442.0% | View Chart |
Dividend Yield | % | 0.0 | 0.3 | - |
INDO US BIO-TECH VENKYS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
VENKYS Mar-23 |
INDO US BIO-TECH/ VENKYS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 2,435 | 5.2% | |
Low | Rs | 25 | 1,420 | 1.8% | |
Sales per share (Unadj.) | Rs | 61.6 | 3,004.7 | 2.0% | |
Earnings per share (Unadj.) | Rs | 7.2 | 50.0 | 14.4% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 75.2 | 10.7% | |
Dividends per share (Unadj.) | Rs | 0 | 6.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.3 | 0.0% | |
Book value per share (Unadj.) | Rs | 54.3 | 921.7 | 5.9% | |
Shares outstanding (eoy) | m | 10.03 | 14.09 | 71.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0.6 | 190.5% | |
Avg P/E ratio | x | 10.4 | 38.5 | 27.0% | |
P/CF ratio (eoy) | x | 9.4 | 25.6 | 36.5% | |
Price / Book Value ratio | x | 1.4 | 2.1 | 66.2% | |
Dividend payout | % | 0 | 12.0 | 0.0% | |
Avg Mkt Cap | Rs m | 754 | 27,156 | 2.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 2,549 | 0.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 42,337 | 1.5% | |
Other income | Rs m | 0 | 377 | 0.1% | |
Total revenues | Rs m | 618 | 42,714 | 1.4% | |
Gross profit | Rs m | 94 | 1,116 | 8.4% | |
Depreciation | Rs m | 8 | 355 | 2.3% | |
Interest | Rs m | 12 | 185 | 6.5% | |
Profit before tax | Rs m | 74 | 953 | 7.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 248 | 0.6% | |
Profit after tax | Rs m | 72 | 705 | 10.3% | |
Gross profit margin | % | 15.2 | 2.6 | 577.3% | |
Effective tax rate | % | 2.0 | 26.0 | 7.6% | |
Net profit margin | % | 11.7 | 1.7 | 704.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 13,421 | 4.5% | |
Current liabilities | Rs m | 123 | 6,646 | 1.8% | |
Net working cap to sales | % | 77.1 | 16.0 | 481.9% | |
Current ratio | x | 4.9 | 2.0 | 241.3% | |
Inventory Days | Days | 1 | 12 | 11.8% | |
Debtors Days | Days | 146,261,410 | 566 | 25,848,985.3% | |
Net fixed assets | Rs m | 90 | 6,727 | 1.3% | |
Share capital | Rs m | 100 | 141 | 71.2% | |
"Free" reserves | Rs m | 445 | 12,845 | 3.5% | |
Net worth | Rs m | 545 | 12,986 | 4.2% | |
Long term debt | Rs m | 17 | 0 | - | |
Total assets | Rs m | 689 | 20,149 | 3.4% | |
Interest coverage | x | 7.2 | 6.2 | 116.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 2.1 | 42.7% | |
Return on assets | % | 12.3 | 4.4 | 277.6% | |
Return on equity | % | 13.3 | 5.4 | 244.8% | |
Return on capital | % | 15.3 | 8.8 | 174.4% | |
Exports to sales | % | 0 | 0.1 | 0.0% | |
Imports to sales | % | 0 | 2.2 | 0.0% | |
Exports (fob) | Rs m | NA | 46 | 0.0% | |
Imports (cif) | Rs m | NA | 914 | 0.0% | |
Fx inflow | Rs m | 0 | 46 | 0.0% | |
Fx outflow | Rs m | 0 | 914 | 0.0% | |
Net fx | Rs m | 0 | -868 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 861 | 0.6% | |
From Investments | Rs m | -67 | -266 | 25.1% | |
From Financial Activity | Rs m | 63 | -450 | -14.0% | |
Net Cashflow | Rs m | 1 | 145 | 1.0% |
Indian Promoters | % | 70.2 | 56.1 | 125.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 1.5 | - | |
FIIs | % | 0.0 | 1.3 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 43.9 | 68.0% | |
Shareholders | 1,166 | 60,599 | 1.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | Venky's |
---|---|---|
1-Day | 8.77% | 0.85% |
1-Month | 26.17% | 14.48% |
1-Year | 113.64% | 17.32% |
3-Year CAGR | 152.58% | 5.73% |
5-Year CAGR | 42.16% | -2.77% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the Venky's share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of Venky's the stake stands at 56.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of Venky's.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
Venky's paid Rs 6.0, and its dividend payout ratio stood at 12.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of Venky's.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.